JAN 05, 2016 6:56 AM PST

The Artificial Pancreas Project Goes to Clinical Trial

WRITTEN BY: Xuan Pham
Patients with type 1 diabetes may be on the verge of getting an artificial pancreas system as a new treatment for their chronic condition. Two new clinical trials will soon be underway to test the effectiveness of this new artificial pancreas system that’s designed to take the guesswork out of monitoring glucose levels.
The artificial pancreas could give diabetic patients a new lease on life.
Diabetes mellitus is one of the most common chronic disorders that is characterized by the body’s inability to regulate blood glucose levels. In type 1 diabetes, insulin is not made in enough quantities because the insulin producing cells (islet cells) are attacked and destroyed by the body’s own immune system. As a result, the body is unable to regulate blood sugar levels normally, and diabetics must take great care in monitoring their activity, diet, and glucose levels. This involves daily blood checks and even insulin injections.

Researchers hope the artificial pancreas will eliminate these steps completely. There are two parts to this artificial system: an implanted insulin pump that receives blood sugar levels every five minutes, and a smartphone that’s programmed to automatically deliver the correct amount of insulin. In addition to the ability to react to body changes, the system is also touted to be clever enough to predict glucose levels in advance. Thus, though the system is not a replica of the biological organ, it should function just like the real thing – regulating blood sugar levels at all times.

"The idea is that this can lead to an improved quality of life for individuals with this disease -- not a solution to diabetes, but a means to really extend the quality of their healthful living. - Francis J. Doyle III, Harvard co-principal investigator and engineering lead on the project.

The system was developed through a collaboration between the University of Virginia (UVA) School of Medicine and the Harvard John A. Paulson School of Engineering and Applied Sciences (SEAS). The teams secured $12.7 million in NIH funding to test this artificial construct in two six-month clinical trials, one of the largest-ever long-term clinical trials for diabetes research.

In the first trial, researchers will test the effectiveness of the artificial pancreas system at controlling blood sugar levels in comparison to a traditional insulin pump in 240 patients with type 1 diabetes.
In the second trial, researchers aim to test an adaptive algorithm function of the artificial pancreas, essentially asking whether the system can predict and regulate blood sugar within an acceptable range. For this trial, they will follow 180 patients who completed the first study for an additional six months.

"The biggest challenge in the design of the artificial pancreas is the inherent uncertainty in the human body. Day to day, hour to hour, the various stresses that impact the human body change the way it responds to insulin-controlling glucose. Physical stresses, anxiety, hormonal swings will all change that balance. To be able to control for those factors we need to see longer intervals of data. This is the first trial where we'll be looking at multi-month intervals of time with cohorts of subjects where we can actually see a long enough window to learn those patterns, to adapt and fine-tune the algorithms, and to improve the overall level of glucose control." – Francis J. Doyle
 

Sources: Harvard press release
About the Author
I am a human geneticist, passionate about telling stories to make science more engaging and approachable. Find more of my writing at the Hopkins BioMedical Odyssey blog and at TheGeneTwist.com.
You May Also Like
JUN 16, 2022
Neuroscience
Caffeine Can Cause Long-Term Changes in the Brain
JUN 16, 2022
Caffeine Can Cause Long-Term Changes in the Brain
It's estimated that as many as 80% of all people partake in the world's most common psychoactive substance, caffeine. Pe ...
JUN 20, 2022
Cancer
Uterine Cancer Mortality is on the Rise
JUN 20, 2022
Uterine Cancer Mortality is on the Rise
Uterine cancer develops when cells in the inner lining of the uterus, known as the endometrium, undergo uncontrolled and ...
JUN 21, 2022
Cancer
Advanced Lung Cancer Diagnosis Linked to Socioeconomic Status
JUN 21, 2022
Advanced Lung Cancer Diagnosis Linked to Socioeconomic Status
Lung cancer remains the leading cause of cancer-related deaths for both males and females, and an estimated 120,000 peop ...
JUN 22, 2022
Technology
Alzheimer's Diagnosis With a Single MRI Scan
JUN 22, 2022
Alzheimer's Diagnosis With a Single MRI Scan
Alzheimer’s, one of the more common forms of dementia, is a condition for which there is currently no cure. Accord ...
JUL 14, 2022
Clinical & Molecular DX
A magnetic bead for every need: Expanding applications with conjugated magnetic beads
JUL 14, 2022
A magnetic bead for every need: Expanding applications with conjugated magnetic beads
Magnetic beads (or superparamagnetic particles) can be used for the isolation and purification of cells, nucleic acids, ...
AUG 09, 2022
Cardiology
Frequent Naps Linked to High Blood Pressure
AUG 09, 2022
Frequent Naps Linked to High Blood Pressure
Frequent napping during the day is associated with a 12% higher risk of high blood pressure and 24% higher risk of strok ...
Loading Comments...